153 related articles for article (PubMed ID: 9344203)
1. The immune response in halo nevi.
Zeff RA; Freitag A; Grin CM; Grant-Kels JM
J Am Acad Dermatol; 1997 Oct; 37(4):620-4. PubMed ID: 9344203
[TBL] [Abstract][Full Text] [Related]
2. Halo congenital nevus undergoing spontaneous regression. Involvement of T-cell immunity in involution and presence of circulating anti-nevus cell IgM antibodies.
Tokura Y; Yamanaka K; Wakita H; Kurokawa S; Horiguchi D; Usui A; Sayama S; Takigawa M
Arch Dermatol; 1994 Aug; 130(8):1036-41. PubMed ID: 8053701
[TBL] [Abstract][Full Text] [Related]
3. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?
Moretti S; Spallanzani A; Pinzi C; Prignano F; Fabbri P
J Cutan Pathol; 2007 Apr; 34(4):301-8. PubMed ID: 17381800
[TBL] [Abstract][Full Text] [Related]
4. Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi.
Bergman W; Willemze R; de Graaff-Reitsma C; Ruiter DJ
J Invest Dermatol; 1985 Jul; 85(1):25-9. PubMed ID: 3159801
[TBL] [Abstract][Full Text] [Related]
5. Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cell clones.
Musette P; Bachelez H; Flageul B; Delarbre C; Kourilsky P; Dubertret L; Gachelin G
J Immunol; 1999 Feb; 162(3):1789-94. PubMed ID: 9973443
[TBL] [Abstract][Full Text] [Related]
6. Melanocyte-specific immune response in a patient with multiple regressing nevi and a history of melanoma.
Speeckaert R; van Geel N; Luiten RM; van Gele M; Speeckaert M; Lambert J; Vermaelen K; Tjin EP; Brochez L
Anticancer Res; 2011 Nov; 31(11):3697-703. PubMed ID: 22110189
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous Involution of Congenital Melanocytic Nevus With Halo Phenomenon.
Lee NR; Chung HC; Hong H; Lee JW; Ahn SK
Am J Dermatopathol; 2015 Dec; 37(12):e137-9. PubMed ID: 26588343
[TBL] [Abstract][Full Text] [Related]
8. Halo giant congenital melanocytic nevus: in vitro immunologic studies.
Berman B; Shaieb AM; France DS; Altchek DD
J Am Acad Dermatol; 1988 Nov; 19(5 Pt 2):954-60. PubMed ID: 3057001
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: primary and metastatic melanoma and halo and giant pigmented nevi.
Edelson RL; Hearing VJ; Dellon AL; Frank M; Edelson EK; Green I
Clin Immunol Immunopathol; 1975 Nov; 4(4):557-68. PubMed ID: 1081937
[No Abstract] [Full Text] [Related]
10. Beta 2 microglobulin expression in normal melanocytes, nevocellular nevi, and malignant melanomas.
Takata M; Hirone T; Matsumura H
J Invest Dermatol; 1989 May; 92(5 Suppl):243S-247S. PubMed ID: 2654298
[TBL] [Abstract][Full Text] [Related]
11. An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions.
Anichini A; Molla A; Mortarini R; Tragni G; Bersani I; Di Nicola M; Gianni AM; Pilotti S; Dunbar R; Cerundolo V; Parmiani G
J Exp Med; 1999 Sep; 190(5):651-67. PubMed ID: 10477550
[TBL] [Abstract][Full Text] [Related]
12. Granulomatous inflammation in nevi undergoing regression (halo phenomenon): a report of 6 cases.
Denianke KS; Gottlieb GJ
Am J Dermatopathol; 2008 Jun; 30(3):233-5. PubMed ID: 18496423
[TBL] [Abstract][Full Text] [Related]
13. The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus.
Bayer-Garner IB; Ivan D; Schwartz MR; Tschen JA
Clin Med Res; 2004 May; 2(2):89-97. PubMed ID: 15931341
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous onset of segmental vitiligo and a halo surrounding a congenital melanocytic naevus.
Hofmann UB; Bröcker EB; Hamm H
Acta Derm Venereol; 2009; 89(4):402-6. PubMed ID: 19688155
[TBL] [Abstract][Full Text] [Related]
15. Dermoscopy, reflectance confocal microscopy and immunohistochemical analysis in melanocytic lesions with Meyerson's phenomenon.
Oliveira A; Arzberger E; Massone C; Fink-Puches R; Zalaudek I; Hofmann-Wellenhof R
Dermatology; 2014; 229(4):297-305. PubMed ID: 25472722
[TBL] [Abstract][Full Text] [Related]
16. Association between natural killer cells and regression in melanocytic lesions.
McKay K; Moore PC; Smoller BR; Hiatt KM
Hum Pathol; 2011 Dec; 42(12):1960-4. PubMed ID: 21676435
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural evidence for destruction in the halo nevus.
Jacobs JB; Edelstein LM; Snyder LM; Fortier N
Cancer Res; 1975 Feb; 35(2):352-7. PubMed ID: 1109801
[TBL] [Abstract][Full Text] [Related]
18. Presence of activated lymphocytes in the peripheral blood of patients with halo nevi.
Baranda L; Torres-Alvarez B; Moncada B; Portales-Pérez D; de la Fuente H; Layseca E; González-Amaro R
J Am Acad Dermatol; 1999 Oct; 41(4):567-72. PubMed ID: 10495377
[TBL] [Abstract][Full Text] [Related]
19. CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12.
Gorbachev AV; Fairchild RL
J Immunol; 2004 Aug; 173(4):2443-52. PubMed ID: 15294958
[TBL] [Abstract][Full Text] [Related]
20. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo.
Le Gal FA; Avril MF; Bosq J; Lefebvre P; Deschemin JC; Andrieu M; Dore MX; Guillet JG
J Invest Dermatol; 2001 Dec; 117(6):1464-70. PubMed ID: 11886510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
